Women's Sexual Health Innovation with Sabrina Johnson, CEO of Dari Bioscience
About this episode
The episode discusses the challenges and innovations in women's sexual health with Sabrina Johnson, CEO of Dare Bioscience.
For decades, men had Viagra. Women were told to relax and have a glass of wine. That imbalance in pharmaceutical innovation is finally changing, but it hasn't been easy. In this episode, I talk with Sabrina Johnson, the founder and CEO of Dare Bioscience the only publicly traded pharmaceutical company focused entirely on women's healthcare. We discuss why the pharmaceutical industry has historically avoided investing in women's sexual health, the stigma and sexism that surrounds female arousal and pleasure, and what it actually takes to develop and bring products to market. Sabrina walks us through the development of Dare to Play, a topical cream for sexual arousal that's coming soon, the science behind how it works, and the extensive clinical trials required to prove safety and efficacy. We also discuss other products in development a probiotic for vaginal health and a once-a-month vaginal ring for menopause with estradiol and progesterone. This is about changing what's possible for women's health. From regulatory hurdles to cultural stigma, the barriers to innovating in women's sexual health are real. In this conversation, we explore how companies can create real world…
More episodes of Gyno Girl Presents: Sex, Drugs & Hormones
- Anxiety, OCD, and ADHD in Kids with Dr. John Parkhurst
- Trauma, Lost Desire, and ART: A Breakthrough Therapy with Brooke Bralove
- Teaching Anatomical Language, AI in Medicine, and Why Three OB-GYNs Stopped Delivering Babies with Dr. Meredith McClure and Dr. Ashley Fuller
Explore listener stats, chart rankings, contacts and more on the Gyno Girl Presents: Sex, Drugs & Hormones podcast page.